Mattatuck Health Care Fac in Waterbury, CT

Mattatuck Health Care Fac is a medicare and medicaid certified nursing home in Waterbury, Connecticut. It is located in New Haven county at 9 Cliff St, Waterbury, Connecticut 06710. You can reach out to the office of Mattatuck Health Care Fac via phone at (203) 573-9924. This skilled nursing facility has 43 federally certified beds with average occupancy rate of 76.28%. Its legal business name is Mattatuck Health Care Facility Inc and has the following ownership type - For Profit - Corporation.

Mattatuck Health Care Fac (Medicare CCN 075432) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2003 (21 years certified) and the last quality survey was conducted in October, 2019.

Name	Mattatuck Health Care Fac
Location	9 Cliff St, Waterbury, Connecticut
Certified By	Medicare and Medicaid
No. of Certified Beds	43
Occupancy Rate	76.28%
Medicare ID (CCN)	075432
Legal Business Name	Mattatuck Health Care Facility Inc
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Mattatuck Health Care Fac from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Mattatuck Health Care Fac are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Mattatuck Health Care Fac give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Injectable sealant found to be biocompatible and effective for fetal tissue repair

A sealant inspired by mussels' ability to stick to surfaces under wet conditions has shown promise in the repair of defects in human fetal membranes, according to a recent Northwestern University study.

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

Selective immunotoxins may help treat liver fibrosis

Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.

InControl Medical supports urinary incontinence awareness effort of Women's Health Foundation

According to a new survey endorsed by the Women's Health Foundation, a national nonprofit organization dedicated to bringing education, funding and research to the field of women's pelvic health, seven out of ten (69%) American women ages 45 or older may not recognize that incontinence may be a signal of a bladder health problem. To raise awareness of this issue among women everywhere, the Foundation has declared November to be Bladder Health Awareness Month.

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

Read more Medical News

› Verified 2 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	1
Total Amount of Fines in Dollars	$8291
Number of Payment Denials	0
Total Number of Penalties	1

The resident survey data of Mattatuck Health Care Fac is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	3.42	14.46
Percentage of long-stay residents who lose too much weight	1.71	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	19.42	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	2.33	1.79
Percentage of long-stay residents with a urinary tract infection	4.04	2.65
Percentage of long-stay residents who have depressive symptoms	0	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	0	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	100	93.87
Percentage of long-stay residents who received an antipsychotic medication	44.12	14.2